Corrigendum to "Hyperprogression, a challenge of PD-1/PD-L1 inhibitors treatments: potential mechanisms and coping strategies" [Biomed. Pharmacother. 150 (2022) 112949].
作者信息
Zhao Li-Ping, Hu Jun-Hu, Hu Die, Wang Hao-Jie, Huang Chang-Gang, Luo Ru-Hua, Zhou Zhao-Huang, Huang Xin-Yun, Xie Tian, Lou Jian-Shu
机构信息
School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China; Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Zhejiang 311121, China; Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
Department of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, NY 10065, USA.
出版信息
Biomed Pharmacother. 2023 Aug;164:114944. doi: 10.1016/j.biopha.2023.114944. Epub 2023 May 29.
Zotero 插件